Література. 
Спонтанний бактеріальний перитоніт у хворих на цироз печінки

перитоніт цироз печінка.

• 1. Singal A. K. Prevalence and in-hospital mortality trends of infections among patients with cirrhosis: a nationwide study of hospitalised patients in the United States / A. K. Singal, H. Salameh, P. S. Kamath // Aliment. Pharmacol. Ther. — 2014. — Vol. 40. — P. 105−112.
• 2. Ascites: aetiology, mortality and the prevalence of spontaneous bacterial peritonitis / J. Khan, P. Pikkarainen, A. L. Karvonen [et al. ] // Scand. J. Gastroenterol. — 2009. — Vol. 44. — P. 970−974.
• 3. Spontaneous bacterial peritonitis: How to deal with this life-threatening cirrhosis complication? / T. C. Ribeiro, J. M. Chebli, M. Kondo [et al. ] // Ther. Clin. Risk Manag. — 2008. — Vol. 4. — P. 919−925.
• 4. Caroli J. Portocaval septicemia; liver cirrhosis & septicemia caused by colibacillus / J. Caroli, R. Platteborse // Sem. Hop. — 1958. — Vol. 34. P. 472−487.
• 5. Kerr D. N. Infection of ascitic fluid in patients with hepatic cirrhosis / D. N. Kerr, D. T. Pearson,

A. E. Read // Gut. — 1963. — Vol. 4. — P. 394−398.

• 6. Conn H. O. Spontaneous peritonitis and bacteremia in Laennec’s cirrhosis caused by enteric organisms. A relatively common but rarely recognized syndrome / H. O. Conn // Ann. Intern. Med. — 1964. — Vol. 60. — P. 568−580.
• 7. Rossiter J. P. Spontaneous bacterial peritonitis: an unusual life-threatening complication of congestive heart failure / J. P. Rossiter, K. Cunningham, P. N. Manley // Can. J. Cardiol. — 2015. — Vol. 31. — P. 691. e13−14.
• 8. Teo S. Spontaneous bacterial peritonitis as a presenting feature of nephrotic syndrome / S. Teo,

A. Walker, A. Steer // J. Paediatr. Child. Health. — 2013. — Vol. 49. — P. 1069−1071.

9. Yildirim B. Patients with spontaneous bacterial peritonitis, and malignant and cirrhotic ascites /.

B. Yildirim, R. Sari, N. Isci // J. Natl. Med. Assoc. — 2005. — Vol. 97. — P. 276−280.

• 10. Spontaneous bacterial peritonitis in isolated splenic vein thrombosis with portal hypertension / N. Gupta, V. Sahni, P. Singh [et al. ] // Indian J. Gastroenterol. — 2006. — Vol. 25. — P. 263−264.
• 11. Skau T. Spontaneous peritonitis and rheumatoid arthritis — a case report / T. Skau, Y. Tegner // Acta Chir. Scand. — 1986. — Vol. 152. — P. 317−318.
• 12. Spontaneous bacterial peritonitis in asymptomatic outpatients with cirrhotic ascites /

L. T. Evans, W. R. Kim, J. J. Poterucha, P. S. Kamath // Hepatology. — 2003. — Vol. 37. — P. 897−901.

13. Low incidence of spontaneous bacterial peritonitis in asymptomatic cirrhotic outpatients /.

J.F. Cadranel, J. B. Nousbaum, C. Bessaguet [et al. ] // World J. Hepatol. — 2013. — Vol. 5. — P. 104−108.

• 14. Singal A. K. Prevalence and in-hospital mortality trends of infections among patients with cirrhosis: a nationwide study of hospitalised patients in the United States / A. K. Singal, H. Salameh, P. S. Kamath // Aliment. Pharmacol. Ther. — 2014. — Vol. 40. — P. 105−112.
• 15. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document / A. Rimola, G. Garcia-Tsao, M. Navasa [et al. ] // J. Hepatol. — 2000. — Vol. 32. — P. 142−153.
• 16. The long-term mortality of spontaneous bacterial peritonitis in cirrhotic patients: A 3-year nationwide cohort study / T. H. Hung, C. C. Tsai, Y. H. Hsieh, C. C. Tsai // Turk. J. Gastroenterol. — 2015. — Vol. 26. — P. 159−162.
• 17. Wiest R. Spontaneous bacterial peritonitis: recent guidelines and beyond / R. Wiest, A. Krag, A. Gerbes // Gut. — 2012. — Vol. 61. — P. 297−310.
• 18. Wiest R. Pathological bacterial translocation in liver cirrhosis / R. Wiest, M. Lawson,

M.Geuking // J. Hepatol. — 2014. — Vol. 60. — P. 197−209.

• 19. Long-term cannabinoid type 2 receptor agonist therapy decreases bacterial translocation in rats with cirrhosis and ascites / Y. Y. Yang, S. L. Hsieh, P. C. Lee [et al. ] // J. Hepatol. — 2014. — Vol. 61. — P. 1004−1013.
• 20. Tang N. Y. Significance of lipopolysaccharide binding protein in serum and ascites of patients with hepatic cirrhosis complicated with spontaneous bacterial peritonitis / N. Y. Tang, W. Q. Chen // Zhonghua Gan Zang Bing Za Zhi. — 2012. — Vol. 20. — P. 492−496.
• 21. Laboratory diagnostics of spontaneous bacterial peritonitis / G. Lippi, E. Danese, G. Cervellin, M. Montagnana // Clin. Chim. Acta. — 2014. — Vol. 430. — P. 164−170.
• 22. Seki E. Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gut / E. Seki, B. Schnabl // J. Physiol. — 2012. — Vol. 590. — P. 447−458.
• 23. Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement / A. Albillos, A. de la Hera, M. Gonzalez [et al. ] // Hepatology. — 2003. — Vol. 37. — P. 208−217.
• 24. Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis / T. Reiberger, A. Ferlitsch, B. A. Payer [et al. ] // J. Hepatol. — 2013. — Vol. 58. — P. 911−921.
• 25. Plasma endotoxin concentration and endotoxin binding capacity of plasma acute phase proteins in cirrhotics with variceal bleeding: an analysis by new methods / H. Fukui, M. Matsumoto, S. Tsujita [et al. ] // J. Gastroenterol. Hepatol. — 1994. — Vol. 9. — P. 582−586.
• 26. Bacterial DNA and its consequences in patients with cirrhosis and culture-negative, nonneutrocytic ascites / M. M. El-Naggar, El-S. A-M. Khalil, M. A. M. El-Daker, M. F. Salama // J. Med. Microbiol. — 2008. — Vol. 57. — P 1533−1538.
• 27. Serum endotoxin and inflammatory mediators in patients with cirrhosis and hepatic encephalopathy / L. Jain, B. C. Sharma, P Sharma [et al. ] // Dig. Liver Dis. — 2012. — Vol. 44. — P 1027−1031.
• 28. Schnabl B. Interactions between the intestinal microbiome and liver diseases / B. Schnabl, D. A. Brenner // Gastroenterology. — 2014. — Vol. 146. — P. 1513−1524.
• 29. Intestinal epithelial barrier function in liver cirrhosis: an extensive review of the literature /K.E. Pijls, D. M. Jonkers, E. E. Elamin [et al. ] // Liver Int. — 2013. — Vol. 33. — P 1457−1469.
• 30. Immune dysfunction in cirrhosis / N. Sipeki, P. Antal-Szalmas, P L. Lakatos, M. Papp // World

J.Gastroenterol. — 2014. — Vol. 20. — P. 2564−2577.

• 31. Dukowicz A. C. Small intestinal bacterial overgrowth: a comprehensive review // A. C. Dukowicz, B. E. Lacy, G. M. Levine // Gastroenterol. Hepatol. — 2007. — Vol. 3. — P. 112−122.
• 32. Marchesi J. The normal intestinal microbiota / J. Marchesi, F. Shanahan // Curr. Opin. Infect. Dis. — 2007. — Vol. 20. — P. 508−513.
• 33. Kalaitzakis E. Gastrointestinal dysfunction in liver cirrhosis / E. Kalaitzakis // World J. Gastroenterol. — 2014. — Vol. 20. — P. 14 686−14 695.
• 34. Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation / J. S. Bajaj, P. B. Hylemon, J. M. Ridlon [et al. ] // Am. J. Physiol. Gastrointest. Liver Physiol. — 2012. — Vol. 303. — G675-G685.
• 35. Bacterial translocation and changes in the intestinal microbiome in mouse models of liver disease / D. E. Fouts, M. Torralba, K. E. Nelson //J. Hepatol. — 2012. — Vol. 56. — P. 1283−1292.
• 36. Fukui H. Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemia / Fukui H. // World J. Hepatol. — 2015. — Vol. 7. — P. 425−442.
• 37. NOD2 gene variants are a risk factor for culture-positive spontaneous bacterial peritonitis and monomicrobial bacterascites in cirrhosis / T. Bruns, J. Peter, P. A. Reuken [et al. ] // Liver Int. — 2012. — Vol. 32. — P. 223−230.
• 38. Strober W. NOD2, an intracellular innate immune sensor involved in host defense and Crohn’s disease / W. Strober, T. Watanabe // Mucosal Immunol. — 2011. — Vol. 4. — P 484−495.
• 39. Toll-like receptor (TLR) 2 promoter and intron 2 polymorphisms are associated with increased risk for spontaneous bacterial peritonitis in liver cirrhosis / H. D. Nischalke, C. Berger, K. Aldenhoff [et al. ] // J. Hepatol. — 2011. — Vol. 55. — P. 1010−1016.
• 40. Molecular detection of monocyte chemotactic protein-1 polymorphism in spontaneous bacterial peritonitis patients / M. K. Salama, D. Sabry, M. A. Al-Ghussein [et al. ] // World J. Gastroenterol. — 2014. — Vol. 20. — P. 11 793−11 799.
• 41. The severity of circulating neutrophil dysfunction in patients with cirrhosis is associated with 90-day and 1-year mortality / N. J. Taylor, G. K. Manakkat Vijay, R. D. Abeles [et al. ] // Aliment. Pharmacol. Ther. — 2014. — Vol. 40. — P. 705−715.
• 42. Opsonophagocytic dysfunction in patients with liver cirrhosis and low responses to tumor necrosis factor-alpha and lipopolysaccharide in patients' blood / Y. Ono, T. Watanabe, K. Matsumoto [et al. ] // J. Infect. Chemother. — 2004. — Vol. 10. — P. 200−207.
• 43. Analysis of T cell activation pathways in patients with liver cirrhosis, impaired delayed hypersensitivity and other T cell-dependent functions / C. A. Schirren, M. C. Jung, R. Zachoval [et al.] // Clin. Exp. Immunol. — 1997. — Vol. 108. — P 144−150.